Related Experiment Video
Updated: May 15, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Opioid-induced respiratory depression in paediatrics: a review of case reports
M Niesters1, F Overdyk, T Smith
1Department of Anesthesiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Insights
Opioid-induced respiratory depression (OIRD) in children is life-threatening. Key risk factors include renal impairment, genetic variations affecting codeine metabolism, and post-adenotonsillectomy use, highlighting specific pediatric OIRD patterns.
Area of Science:
- Pediatric Anesthesiology
- Clinical Pharmacology
- Pharmacogenetics
Background:
- Opioids are essential for pediatric pain management but carry risks.
- Opioid-induced respiratory depression (OIRD) incidence in children is unknown.
- Understanding OIRD patterns is crucial for pediatric patient safety.
Purpose of the Study:
- To identify specific patterns and risk factors for OIRD in pediatric patients.
- To analyze case reports of OIRD in children aged 12 years or younger.
- To investigate OIRD development in both medically treated and perinatal exposure cases.
Main Methods:
- Systematic search of PubMed for OIRD case reports up to May 2012.
- Inclusion of pediatric patients (≤12 years) requiring naloxone, intubation, or resuscitation.
- Analysis of 27 cases from 24 reports to identify distinct OIRD development patterns.
Main Results:
- Seven of the 27 cases were fatal.
- Eight cases resulted from iatrogenic overdose.
- Identified patterns: morphine accumulation in renal impairment, enhanced morphine from codeine in CYP2D6 ultra-rapid metabolizers, and OIRD post-adenotonsillectomy potentially linked to hypoxia.
Conclusions:
- Specific risk factors contribute to OIRD in pediatric populations.
- Renal impairment, CYP2D6 gene polymorphism, and post-adenotonsillectomy status are critical considerations.
- Further research is needed to refine management strategies and improve safety.
Abstract:
Opioids remain the cornerstone of modern-day pain treatment, also in the paediatric population. Opioid treatment is potentially life-threatening, although there are no numbers available on the incidence of opioid-induced respiratory depression (OIRD) in paediatrics. To get an indication of specific patterns in the development/causes of OIRD, we searched PubMed (May 2012) for all available case reports on OIRD in paediatrics, including patients 12 yr of age or younger who developed OIRD from an opioid given to them for a medical indication or due to transfer of an opioid from their mother in the perinatal setting, requiring naloxone, tracheal intubation, and/or resuscitation. Twenty-seven cases are described in 24 reports; of which, seven cases were fatal. In eight cases, OIRD was due to an iatrogenic overdose. Three distinct patterns in the remaining data set specifically related to OIRD include: (i) morphine administration in patients with renal impairment, causing accumulation of the active metabolite of morphine; (ii) codeine use in patients with CYP2D6 gene polymorphism associated with the ultra-rapid metabolizer phenotype, causing enhanced production of the morphine; and (iii) opioid use in patients after adenotonsillectomy for recurrent tonsillitis and/or obstructive sleep apnoea, where OIRD may be related to hypoxia-induced enhancement of OIRD. Despite the restrictions of this approach, our analysis does yield an important insight in the development of OIRD, with specific risk factors clearly present in the data.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pharmacokinetics in Pediatric Patients: Drug Excretion